Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?

Affiliations

¹ Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth. Department of Neurology, Sir Charles Gairdner Hospital, Perth, Australia.

Editorial

Graeme J Hankey. Circulation. 2021.

. 2021 Nov 30;144(22):1747-1749.

doi: 10.1161/CIRCULATIONAHA.121.057615. Epub 2021 Nov 29.

¹ Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth. Department of Neurology, Sir Charles Gairdner Hospital, Perth, Australia.

No abstract available

Keywords: Editorials; anticoagulant; atrial fibrillation; stroke.

Comment on

Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Bahit MC, Sacco RL, Easton JD, Meyerhoff J, Cronin L, Kleine E, Grauer C, Brueckmann M, Diener HC, Lopes RD, Brainin M, Lyrer P, Wachter R, Segura T, Granger CB; RE-SPECT ESUS Steering Committee and Investigators. Bahit MC, et al. Circulation. 2021 Nov 30;144(22):1738-1746. doi: 10.1161/CIRCULATIONAHA.121.055176. Epub 2021 Oct 15. Circulation. 2021. PMID: 34649459 Clinical Trial.